Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Gunnlaugur Petur Nielsen, M.D.

Co-Author

This page shows the publications co-authored by Gunnlaugur Nielsen and Joseph Schwab.
Connection Strength

2.438
  1. Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors. Clin Orthop Relat Res. 2021 06 01; 479(6):1373-1382.
    View in: PubMed
    Score: 0.228
  2. High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease. Front Oncol. 2021; 11:598001.
    View in: PubMed
    Score: 0.226
  3. Dedifferentiated Chordoma: Clinicopathologic and Molecular Characteristics With Integrative Analysis. Am J Surg Pathol. 2020 09; 44(9):1213-1223.
    View in: PubMed
    Score: 0.216
  4. Histopathology of synovial cysts of the spine. Histopathology. 2018 May; 72(6):923-929.
    View in: PubMed
    Score: 0.182
  5. Primary thoracic giant cell tumor of bone sensitive to steroids. Skeletal Radiol. 2018 Oct; 47(10):1431-1435.
    View in: PubMed
    Score: 0.182
  6. CSPG4 as a prognostic biomarker in chordoma. Spine J. 2016 06; 16(6):722-7.
    View in: PubMed
    Score: 0.156
  7. A 33-year-old man with low back pain. Clin Orthop Relat Res. 2014 Apr; 472(4):1345-50.
    View in: PubMed
    Score: 0.137
  8. Epithelioid hemangioma of the spine: a case series of six patients and review of the literature. Spine J. 2013 Dec; 13(12):e7-13.
    View in: PubMed
    Score: 0.134
  9. Chondrosarcoma of the mobile spine: a review of 21 cases treated at a single center. Spine (Phila Pa 1976). 2012 Jan 15; 37(2):119-26.
    View in: PubMed
    Score: 0.119
  10. Intraosseous synovial sarcoma of the proximal tibia. Int J Surg Oncol. 2011; 2011:184891.
    View in: PubMed
    Score: 0.114
  11. Assessing the Safety and Utility of Wound VAC Temporization of the Sarcoma or Benign Aggressive Tumor Bed Until Final Margins Are Achieved. Ann Surg Oncol. 2022 Apr; 29(4):2290-2298.
    View in: PubMed
    Score: 0.059
  12. Clinical Utility of Anchored Multiplex Solid Fusion Assay for Diagnosis of Bone and Soft Tissue Tumors. Am J Surg Pathol. 2021 08 01; 45(8):1127-1137.
    View in: PubMed
    Score: 0.058
  13. Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution. Sarcoma. 2019; 2019:9069272.
    View in: PubMed
    Score: 0.051
  14. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis. Clin Orthop Relat Res. 2019 Sep; 477(9):2114-2126.
    View in: PubMed
    Score: 0.050
  15. Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST. Radiother Oncol. 2019 08; 137:61-70.
    View in: PubMed
    Score: 0.049
  16. Clinicopathologic characteristics of poorly differentiated chordoma. Mod Pathol. 2018 08; 31(8):1237-1245.
    View in: PubMed
    Score: 0.045
  17. Frequency and Risk Factors for Additional Lesions in the Axial Spine in Subjects With Chordoma: Indications for Screening. Spine (Phila Pa 1976). 2017 Jan 01; 42(1):E37-E40.
    View in: PubMed
    Score: 0.042
  18. Differences in sex distribution, anatomic location and MR imaging appearance of pediatric compared to adult chordomas. BMC Med Imaging. 2016 09 08; 16(1):53.
    View in: PubMed
    Score: 0.041
  19. Surgical management of Gorham-Stout disease of the pelvis refractory to medical and radiation therapy. Am J Orthop (Belle Mead NJ). 2015 Nov; 44(11):E473-7.
    View in: PubMed
    Score: 0.039
  20. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors. J Neurosurg Spine. 2015 Dec; 23(6):788-97.
    View in: PubMed
    Score: 0.038
  21. Programmed cell death ligand 1 expression in osteosarcoma. Cancer Immunol Res. 2014 Jul; 2(7):690-698.
    View in: PubMed
    Score: 0.035
  22. Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas. J Surg Oncol. 2014 Aug; 110(2):115-22.
    View in: PubMed
    Score: 0.035
  23. Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma. PLoS One. 2013; 8(9):e75851.
    View in: PubMed
    Score: 0.033
  24. The use of radiation therapy in the management of selected patients with atypical lipomas. Sarcoma. 2013; 2013:485483.
    View in: PubMed
    Score: 0.032
  25. Do histologic criteria predict biologic behavior of giant cell lesions? J Oral Maxillofac Surg. 2012 Nov; 70(11):2573-80.
    View in: PubMed
    Score: 0.030
  26. Recurrent chromosomal copy number alterations in sporadic chordomas. PLoS One. 2011; 6(5):e18846.
    View in: PubMed
    Score: 0.028
  27. Characterization and analysis of human chordoma cell lines. Spine (Phila Pa 1976). 2010 Jun 01; 35(13):1257-64.
    View in: PubMed
    Score: 0.027
  28. An effective preoperative three-dimensional radiotherapy target volume for extremity soft tissue sarcoma and the effect of margin width on local control. Int J Radiat Oncol Biol Phys. 2010 Jul 01; 77(3):843-50.
    View in: PubMed
    Score: 0.026
  29. A novel target for treatment of chordoma: signal transducers and activators of transcription 3. Mol Cancer Ther. 2009 Sep; 8(9):2597-605.
    View in: PubMed
    Score: 0.025
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.